Intuitive Surgical, Inc. $ISRG Stock Position Boosted by Unio Capital LLC

Unio Capital LLC increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 17.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 57,918 shares of the medical equipment provider’s stock after buying an additional 8,694 shares during the quarter. Intuitive Surgical comprises approximately 6.2% of Unio Capital LLC’s portfolio, making the stock its 8th biggest holding. Unio Capital LLC’s holdings in Intuitive Surgical were worth $32,802,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. Kemnay Advisory Services Inc. purchased a new position in shares of Intuitive Surgical in the 4th quarter worth about $79,000. Captrust Financial Advisors raised its holdings in shares of Intuitive Surgical by 23.6% in the 4th quarter. Captrust Financial Advisors now owns 34,555 shares of the medical equipment provider’s stock worth $19,571,000 after purchasing an additional 6,589 shares during the period. Fred Alger Management LLC raised its holdings in shares of Intuitive Surgical by 30.0% in the 4th quarter. Fred Alger Management LLC now owns 350,972 shares of the medical equipment provider’s stock worth $198,777,000 after purchasing an additional 81,062 shares during the period. &PARTNERS raised its holdings in shares of Intuitive Surgical by 24.2% in the 4th quarter. &PARTNERS now owns 29,675 shares of the medical equipment provider’s stock worth $16,805,000 after purchasing an additional 5,783 shares during the period. Finally, ExodusPoint Capital Management LP raised its holdings in shares of Intuitive Surgical by 17.2% in the 4th quarter. ExodusPoint Capital Management LP now owns 20,398 shares of the medical equipment provider’s stock worth $11,553,000 after purchasing an additional 2,999 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, SVP Iman Jeddi sold 5,625 shares of the stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the completion of the sale, the executive vice president owned 5,720 shares of the company’s stock, valued at approximately $2,426,080.80. This trade represents a 6.54% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 7,169 shares of company stock worth $3,059,135. 0.60% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

ISRG stock opened at $417.07 on Wednesday. Intuitive Surgical, Inc. has a 1 year low of $396.68 and a 1 year high of $603.88. The firm has a market cap of $147.71 billion, a P/E ratio of 50.55, a price-to-earnings-growth ratio of 3.39 and a beta of 1.46. The stock has a 50-day simple moving average of $441.47 and a 200-day simple moving average of $493.43.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. During the same quarter last year, the firm earned $1.81 earnings per share. The company’s revenue for the quarter was up 23.0% compared to the same quarter last year. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Analyst Ratings Changes

A number of research firms have recently commented on ISRG. Bank of America cut their price objective on Intuitive Surgical from $520.00 to $515.00 in a report on Friday, June 12th. Mizuho set a $525.00 price objective on Intuitive Surgical and gave the stock a “neutral” rating in a report on Monday, April 13th. The Goldman Sachs Group set a $558.00 price objective on Intuitive Surgical in a report on Wednesday, May 27th. JPMorgan Chase & Co. cut their price objective on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Finally, Evercore cut their price objective on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating on the stock in a report on Monday, April 6th. Nineteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $573.42.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.